NDRA
NDRA
NASDAQ · Health Care

Endra Life Sciences Inc

$5.74
+0.08 (+1.41%)
As of May 16, 2:34 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +463.4% upside
Low Target $22.21
Average Target $32.34
High Target $49.71
Current Price $5.74
Current
$5.74
Target
$32.34
$22.21 $32.34 avg $49.71
Scenario Analysis
Bear Case
$22.21
286.9%
Low target
Base Case
$32.34
+463.4%
Avg target
Bull Case
$49.71
+766.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$11.96
-52.0% from high
52-Week Low
$2.90
+97.9% from low
Target vs 52W High
$32.34
+170.4% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 34 76% $293.85 -25.4%
ISRG
Intuitive Surgical Inc
Buy 41 71% $219.77 -47.8%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +46.2%
CVS
Cvs Health Corp
Strong Buy 33 76% $162.09 +69.0%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +10.3%
MDT
Medtronic Plc
Buy 37 62% $192.46 +152.7%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -71.9%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -59.6%